Web Results

Fondaparinux - Wikipedia


Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline.

Arixtra (fondaparinux) dosing, indications, interactions, adverse ...


Medscape - Indication-specific dosing for Arixtra (fondaparinux), frequency- based adverse effects, comprehensive interactions, contraindications, pregnancy  ...

Fondaparinux: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for fondaparinux. Includes indications, proper use, special instructions, precautions, and possible side effects.

Fondaparinux medical facts from Drugs.com


Physician reviewed fondaparinux patient information - includes fondaparinux description, dosage and directions.

Arixtra (Fondaparinux Sodium): Side Effects, Interactions, Warning ...


Learn about Arixtra (Fondaparinux Sodium) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Arixtra (Fondaparinux Sodium) Drug Information: Indications ...


Learn about indications, dosage and how it is supplied for the drug Arixtra ( Fondaparinux Sodium).

Arixtra (Fondaparinux Sodium) Drug Information: Clinical ...


Learn about clinical pharmacology for the drug Arixtra (Fondaparinux Sodium).

arixtra - FDA


ARIXTRA® (fondaparinux sodium) Injection is a sterile solution containing fondaparinux sodium. It is a synthetic and specific inhibitor of activated Factor X ( Xa).

Arixtra Fondaparinux sodium solution for injection 2,5 mg/ 0,5 ml ...


Oct 14, 2016 ... The first fondaparinux administration should be given not earlier than 6 hours following surgical closure. The injection should not be given ...

Fondaparinux: Dosing and adverse effects - UpToDate


May 31, 2016 ... Fondaparinux (Arixtra) is a synthetic anticoagulant based on the pentasaccharide sequence that makes up the minimal antithrombin (AT) ...